The therapeutic efficacy of interferon alpha (IFNα) is well-established in various conditions, including Hepatitis B and C, lymphoma and skin cancer, attributed to its potent angiostatic, immunomodulatory, and antiproliferative properties. Clinical applications using this bioactive are, however, hindered by systemic to...
Magdi Abobaker, Mershen Govender, Y. Choonara· AAPS PharmSciTech· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.